jamunjar-logo
whatsapp
cartmembermenu
Search for
"test & packages"
"physiotherapy"
"heart"
"lungs"
"diabetes"
"kidney"
"liver"
"cancer"
"thyroid"
"bones"
"fever"
"vitamin"
"iron"
"HTN"

Sex Hormone Binding Globulin (SHBG)

Reproductive
image

Report in 4Hrs

image

At Home

nofastingrequire

No Fasting Required

Details

Glycoprotein produced mainly by the liver that binds to sex hormones

459660

30% OFF

Sex Hormone Binding Globulin (SHBG) - Comprehensive Test Guide

  • Why is it done?
    • Test Purpose: Measures the level of Sex Hormone Binding Globulin (SHBG), a protein produced primarily by the liver that binds to testosterone, estrogen, and other steroid hormones in the blood, regulating their availability and biological activity.
    • Primary Indications: Evaluating hormonal imbalances, investigating infertility, assessing polycystic ovary syndrome (PCOS), evaluating hirsutism and acne, diagnosing hypogonadism or testosterone deficiency, and monitoring hormonal therapy effectiveness.
    • Typical Circumstances: Often ordered as part of comprehensive hormone panel with testosterone and estrogen levels; performed during investigation of symptoms suggesting hormonal dysfunction; used in conjunction with other metabolic markers to assess insulin resistance and metabolic syndrome.
  • Normal Range
    • Reference Values: Adults - 24-122 nmol/L (nanomoles per liter) or 7-36 ng/mL (nanograms per milliliter) Women: Typically 24-122 nmol/L or 7-36 ng/mL Men: Typically 10-57 nmol/L or 3-12 ng/mL Ranges vary by laboratory and may differ based on age, menopausal status, and hormonal contraceptive use.
    • Units of Measurement: nmol/L (SI units - standard internationally) or ng/mL (conventional units used in some North American laboratories)
    • Result Interpretation: Normal Range - SHBG within reference values indicates appropriate hormone-binding capacity Low SHBG - Below reference range; associated with increased free hormone levels High SHBG - Above reference range; associated with decreased free hormone availability Interpretation requires correlation with total and free testosterone/estrogen levels and clinical presentation.
    • Clinical Significance: Normal SHBG suggests appropriate regulation of free hormone availability; abnormal values may explain symptoms despite normal total hormone levels; SHBG levels are more stable than fluctuating hormone levels and provide important context for interpreting hormone panel results.
  • Interpretation
    • High SHBG Levels: Indicates increased binding of hormones, resulting in lower bioavailable (free) testosterone and estrogen; associated with hyperthyroidism, liver disease, estrogen use/therapy, pregnancy, and eating disorders; may contribute to symptoms of hormone deficiency despite normal total hormone levels.
    • Low SHBG Levels: Indicates decreased binding capacity, resulting in increased free hormone levels; commonly associated with insulin resistance, PCOS, metabolic syndrome, obesity, type 2 diabetes, and hypothyroidism; may explain symptoms of androgen or estrogen excess; correlates with increased cardiovascular and metabolic risk.
    • Factors Affecting Results: Insulin levels - inversely correlated; hyperinsulinemia decreases SHBG Body weight and composition - obesity lowers SHBG; weight loss increases SHBG Thyroid function - hyperthyroidism increases SHBG; hypothyroidism decreases SHBG Estrogen status - exogenous estrogen and pregnancy increase SHBG Liver function - liver disease may impair SHBG production Age - SHBG typically increases with age, especially in men Medications - corticosteroids, tamoxifen, and anticonvulsants can affect levels Ethnicity and genetic factors may influence baseline SHBG levels.
    • Clinical Significance Patterns: Low SHBG + High Testosterone - Strongly suggestive of PCOS or androgen excess Low SHBG + Normal Total Testosterone - May indicate elevated free testosterone with clinical symptoms High SHBG + Low Free Testosterone - Suggests inadequate bioavailable hormone despite normal total levels SHBG changes over time - Progressive decline may indicate developing insulin resistance or metabolic syndrome SHBG in context of other markers - Most useful when interpreted with free testosterone, total testosterone, insulin, and metabolic markers.
  • Associated Organs
    • Primary Organs Involved: Liver - Primary site of SHBG production and synthesis; liver dysfunction directly impacts SHBG levels Hypothalamus and Pituitary - Regulate gonadal hormone production, which indirectly affects SHBG metabolism Ovaries and Testes - Produce testosterone and estrogen that interact with SHBG Thyroid Gland - Thyroid hormones regulate SHBG production Pancreas - Insulin directly suppresses hepatic SHBG production, inversely correlating with SHBG levels.
    • Conditions Associated with Abnormal SHBG: Polycystic Ovary Syndrome (PCOS) - Low SHBG with elevated free androgens Insulin Resistance - Hyperinsulinemia suppresses SHBG production Metabolic Syndrome - Multiple metabolic abnormalities associated with low SHBG Type 2 Diabetes - Insulin resistance leads to decreased SHBG Hypothyroidism - Reduced SHBG production Hyperthyroidism - Elevated SHBG levels Obesity - Associated with low SHBG and insulin resistance Fatty Liver Disease - Liver dysfunction may impair SHBG synthesis Cirrhosis and Hepatitis - Severe liver disease impairs SHBG production Hyperandrogenism - May result from or cause low SHBG Hypogonadism - High SHBG may mask low free testosterone Pregnancy - Physiologic elevation of SHBG Eating Disorders (Anorexia) - Malnutrition increases SHBG
    • Associated Complications: Low SHBG complications - Increased cardiovascular risk, metabolic dysfunction, increased cancer risk (certain types), infertility issues, and difficulty managing hormonal symptoms High SHBG complications - Reduced bone density risk, hormonal deficiency symptoms despite normal total hormones, decreased sexual function, and reduced insulin sensitivity Diagnostic complications - May mask or misdiagnose hormonal disorders if total hormone levels are normal but free hormone levels are abnormal Treatment complications - Changes in SHBG during weight loss or hormone therapy can affect treatment efficacy and require dosage adjustments.
  • Follow-up Tests
    • Recommended Additional Tests: Free Testosterone - Essential for interpreting SHBG results and assessing bioavailable hormone levels Total Testosterone - Comprehensive hormone assessment; interpret in context of SHBG Free Estradiol - Evaluate free estrogen levels if SHBG abnormalities are identified Total Estradiol - Complete hormonal picture in women Luteinizing Hormone (LH) - Assess pituitary function and reproductive hormone axis Follicle Stimulating Hormone (FSH) - Evaluate gonadal function Insulin Fasting - Assess insulin resistance given inverse relationship with SHBG Glucose (Fasting) - Screen for diabetes and metabolic dysfunction Thyroid Stimulating Hormone (TSH) - Evaluate thyroid function as it affects SHBG Free T4 and T3 - If TSH abnormal, assess thyroid hormone levels Liver Function Panel - Assess hepatic synthetic function if SHBG abnormal Lipid Panel - Evaluate cardiovascular risk in metabolic syndrome Hemoglobin A1C - Assess long-term glucose control Prolactin - Evaluate if reproductive dysfunction present Androstenedione and DHEA-S - Further androgen assessment if hyperandrogenism suspected
    • Further Investigations: Pelvic Ultrasound - If PCOS suspected (look for ovarian cysts) Transvaginal Ultrasound - Detailed ovarian and uterine assessment in women Abdominal Ultrasound - Assess for fatty liver disease if metabolic dysfunction Oral Glucose Tolerance Test (OGTT) - If insulin resistance or prediabetes suspected Continuous Glucose Monitoring - In selected cases with metabolic dysfunction Imaging Studies - May be indicated if pituitary or hypothalamic pathology suspected Genetic Testing - In selected cases where genetic hormonal disorders suspected
    • Monitoring Frequency: Initial Diagnosis - Baseline SHBG with comprehensive hormone panel With Treatment Initiation - Recheck 6-8 weeks after starting therapy to assess response With Lifestyle Modifications - Retest 3-6 months after weight loss, exercise, or dietary changes Chronic Management - Annual or biannual testing for patients with PCOS, metabolic syndrome, or hypogonadism Hormone Replacement Therapy - Every 6-12 months to assess adequacy of dosing Response Monitoring - Variable frequency based on clinical response and symptoms Long-term Surveillance - Regular monitoring if conditions associated with significant health risks
    • Related Complementary Tests: Testosterone/SHBG Ratio - Provides estimate of free testosterone when direct free testosterone measurement unavailable Free Androgen Index (FAI) - Calculated as (total testosterone/SHBG) × 100; useful PCOS marker Metabolic Markers - Adiponectin, leptin, inflammatory markers (CRP, TNF-alpha) Bone Markers - If hypogonadism or hormone deficiency affecting bone health Cardiovascular Risk Markers - Lipoprotein(a), homocysteine, if metabolic dysfunction Body Composition Analysis - DEXA scan, bioimpedance analysis for comprehensive metabolic assessment
  • Fasting Required?
    • Fasting Status: No - Fasting is NOT required for SHBG testing SHBG levels are relatively stable throughout the day and unaffected by food or drink intake May be drawn fasting or non-fasting without affecting result accuracy.
    • Special Timing Considerations: Morning testing preferred - Best to draw in early morning (8-10 AM) when hormone levels are typically more stable Menstrual cycle timing - In women with regular cycles, testing is ideally performed in follicular phase (days 2-5 of cycle) for standardized results Consistent timing - If retesting for comparison, try to draw at similar time of day as initial test Avoid testing timing post-exercise - Some recommend avoiding testing immediately after vigorous exercise
    • Medications to Avoid or Consider: Oral Contraceptives - Increase SHBG; may need to note on lab requisition; consider timing of testing in relation to pill use Hormone Replacement Therapy - Will affect SHBG levels; note dosage and duration on requisition Corticosteroids - May alter SHBG; document use with lab Anticonvulsants (Phenytoin) - May affect SHBG; inform laboratory Estrogen-containing products - Including patches, creams, topical formulations Androgens/Testosterone - Will affect SHBG through feedback mechanisms Tamoxifen - May increase SHBG Anabolic Steroids - Will suppress SHBG Other medications - Generally do not require discontinuation; inform provider and laboratory of all current medications
    • Patient Preparation Requirements: General Preparation - No special preparation needed beyond standard venipuncture requirements Hydration - Normal fluid intake is acceptable; not necessary to drink extra water Activity Level - No need to restrict exercise; avoid strenuous activity immediately before test only if possible Stress Management - Minimize stress if possible, but not a strict requirement Clothing - Wear loose, comfortable clothing for easy blood draw Identification - Bring photo ID and insurance information to lab Appointment Timing - Plan appointment for early morning if possible (8-10 AM preferred) Women - Note first day of last menstrual period and current cycle day if applicable Medication List - Bring complete list of all current medications and supplements Lab Requisition - Ensure provider completes lab order with relevant clinical information including symptoms, suspected diagnoses, and current treatments to aid in result interpretation

How our test process works!

customers
customers